The chart below shows how DOC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, DOC sees a -0.48% change in stock price 10 days leading up to the earnings, and a -0.37% change 10 days following the report. On the earnings day itself, the stock moves by -0.41%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Earnings Growth Indicators: FFO per share increased by 12% over the past three years, with AFFO per share growing by 19%, indicating strong earnings growth.
Consistent Same Store Growth: The company reported a total portfolio same store growth of 5.4% for both Q4 and the full year, showcasing consistent operational performance.
Outpatient Segment Performance: In Q4, the outpatient medical segment achieved a same store growth of 3.2%, with a tenant retention rate of 88%, both metrics exceeding industry averages.
CCRC Same Store Growth: The CCRC segment experienced a remarkable same store growth of 20.8%, driven by better-than-expected occupancy gains and entrance fees.
Asset Sales and Cap Rate: Healthpeak closed $1.3 billion in asset sales at a compelling cap rate of 6.4%, enhancing its balance sheet and providing dry powder for future investments.
Negative
FFO Decline Analysis: FFO as adjusted for Q4 was $0.46 per share, which is a decrease from the previous quarter, indicating potential challenges in maintaining earnings momentum.
Same Store Growth Decline: 2025 guidance for total same store growth is projected to decline to 3% to 4%, down from 5.4% in 2024, reflecting a slowdown in growth expectations across segments.
Rising Interest Expenses Impact: Interest expenses are expected to increase by approximately $15 million or $0.02 per share due to refinancing maturing bonds, which could pressure overall profitability.
Earnings Drag Anticipated: The company anticipates a drag on earnings in 2025 due to increased capital expenditures of $600 million, primarily focused on development and redevelopment, which may not yield immediate returns.
Lease Timing Impact: Despite a strong performance in 2024, the company has indicated that the benefits from signed leases will not commence until late 2025, creating a timing lag that could impact short-term earnings.
Earnings call transcript: Healthpeak Properties Q4 2024 misses EPS forecast
DOC.N
-0.15%